Cardiovascular disease is a key contributor to excess morbidity and premature mortality in diabetes and chronic kidney disease is an independent and major risk factor for cardiovascular disease. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for diabetic patients with concomitant renal disease. This report provides a detailed rationale in association with the guidelines, as well as recommendations for clinical audit and outstanding questions for further research. 

A significant percentage of patients with diabetes develop chronic kidney disease (CKD), and diabetes is also a leading cause of end-stage renal disease.  More than a quarter of patients who are on dialysis in the UK have diabetes.  Diabetic kidney disease is associated with high morbidity and mortality, which are predominantly related to cardiovascular complications and the progression of kidney disease that requires renal replacement therapy. Hypertension is a modifiable risk factor for cardiovascular complications and progression of CKD.3

After canvassing the membership interest from four excellent candidates was expressed and an election was held.  I am delighted to announce that Dr Andy Macklin was successfully elected and will be shadowing Tony Robinson, our current treasurer, for the next few months before taking over in the spring.   

Our sincere thanks go to Dr Tony Robinson for all his hard work, dedication and pragmatism, following a very successful 4 years in post. 

Joining Instructions to see this important webinar on

“FLASH GLUCOSE MONITORING & CONTINUOUS GLUCOSE MONITORING”

Tuesday 27th February 2018

5.00 – 6.00pm

Agenda & speakers;

A must see webinar on: "Flash Glucose Monitoring & Continuous Glucose Monitoring"

Tuesday 27th February 5.00 – 6.00pm

Agenda & Speakers: